IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)
INR 434.5
(7.04%)
INR 434.5
(7.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 21.32 Billion INR | -3.8% |
| 2022 | 22.17 Billion INR | 2.25% |
| 2021 | 21.68 Billion INR | 11.42% |
| 2020 | 19.46 Billion INR | 4.43% |
| 2019 | 18.63 Billion INR | 12.6% |
| 2018 | 16.55 Billion INR | 72.01% |
| 2017 | 9.62 Billion INR | 35.39% |
| 2016 | 7.1 Billion INR | 22.44% |
| 2015 | 5.8 Billion INR | 50.86% |
| 2014 | 3.84 Billion INR | -31.73% |
| 2013 | 5.63 Billion INR | 17.03% |
| 2012 | 4.81 Billion INR | 2.3% |
| 2011 | 4.7 Billion INR | 20.87% |
| 2010 | 3.89 Billion INR | 11.44% |
| 2009 | 3.49 Billion INR | 15.76% |
| 2008 | 3.01 Billion INR | -5.06% |
| 2007 | 3.17 Billion INR | 56.94% |
| 2006 | 2.02 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.02 Billion INR | -0.31% |
| 2023 FY | 21.32 Billion INR | -3.8% |
| 2023 Q1 | 5.63 Billion INR | -4.09% |
| 2023 Q2 | 5.45 Billion INR | -3.17% |
| 2023 Q3 | 5.2 Billion INR | -4.57% |
| 2023 Q4 | 5.03 Billion INR | -3.16% |
| 2022 FY | 22.17 Billion INR | 2.25% |
| 2022 Q2 | 5.41 Billion INR | -4.18% |
| 2022 Q3 | 5.23 Billion INR | -3.31% |
| 2022 Q1 | 5.65 Billion INR | 1.47% |
| 2022 Q4 | 5.87 Billion INR | 12.17% |
| 2021 Q1 | 5.18 Billion INR | 17.97% |
| 2021 Q2 | 5.37 Billion INR | 3.74% |
| 2021 FY | 21.68 Billion INR | 11.42% |
| 2021 Q3 | 5.55 Billion INR | 3.21% |
| 2021 Q4 | 5.56 Billion INR | 0.31% |
| 2020 Q3 | 5.13 Billion INR | -3.84% |
| 2020 FY | 19.46 Billion INR | 4.43% |
| 2020 Q1 | 4.6 Billion INR | 12.09% |
| 2020 Q4 | 4.39 Billion INR | -14.32% |
| 2020 Q2 | 5.33 Billion INR | 15.95% |
| 2019 Q2 | 4.48 Billion INR | -8.9% |
| 2019 Q3 | 5.11 Billion INR | 13.87% |
| 2019 Q4 | 4.1 Billion INR | -19.71% |
| 2019 FY | 18.63 Billion INR | 12.6% |
| 2019 Q1 | 4.92 Billion INR | 25.72% |
| 2018 Q4 | 3.91 Billion INR | -18.05% |
| 2018 Q2 | 4.22 Billion INR | 16.88% |
| 2018 FY | 16.55 Billion INR | 72.01% |
| 2018 Q1 | 3.61 Billion INR | 25.85% |
| 2018 Q3 | 4.78 Billion INR | 13.09% |
| 2017 Q1 | 2.15 Billion INR | 11.39% |
| 2017 FY | 9.62 Billion INR | 35.39% |
| 2017 Q4 | 2.87 Billion INR | 9.46% |
| 2017 Q3 | 2.62 Billion INR | 20.61% |
| 2017 Q2 | 2.17 Billion INR | 1.15% |
| 2016 FY | 7.1 Billion INR | 22.44% |
| 2016 Q2 | 1.72 Billion INR | 6.4% |
| 2016 Q3 | 1.83 Billion INR | 6.2% |
| 2016 Q1 | 1.61 Billion INR | 13.93% |
| 2016 Q4 | 1.93 Billion INR | 5.61% |
| 2015 Q2 | 1.58 Billion INR | 15.48% |
| 2015 Q4 | 1.42 Billion INR | -0.67% |
| 2015 Q1 | 1.36 Billion INR | 83.01% |
| 2015 Q3 | 1.43 Billion INR | -9.48% |
| 2015 FY | 5.8 Billion INR | 50.86% |
| 2014 Q4 | 748.27 Million INR | 10.37% |
| 2014 Q3 | 677.94 Million INR | -44.08% |
| 2014 Q1 | 1.2 Billion INR | -6.81% |
| 2014 FY | 3.84 Billion INR | -31.73% |
| 2014 Q2 | 1.21 Billion INR | 0.31% |
| 2013 Q4 | 1.29 Billion INR | -6.76% |
| 2013 Q2 | 1.54 Billion INR | 11.35% |
| 2013 Q1 | 1.39 Billion INR | 2.69% |
| 2013 Q3 | 1.39 Billion INR | -10.22% |
| 2013 FY | 5.63 Billion INR | 17.03% |
| 2012 Q4 | 1.35 Billion INR | 15.76% |
| 2012 Q3 | 1.17 Billion INR | 12.33% |
| 2012 Q2 | 1.04 Billion INR | -16.48% |
| 2012 Q1 | 1.24 Billion INR | 0.0% |
| 2012 FY | 4.81 Billion INR | 2.3% |
| 2011 FY | 4.7 Billion INR | 20.87% |
| 2010 FY | 3.89 Billion INR | 11.44% |
| 2009 FY | 3.49 Billion INR | 15.76% |
| 2008 FY | 3.01 Billion INR | -5.06% |
| 2007 FY | 3.17 Billion INR | 56.94% |
| 2006 FY | 2.02 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sigachi Industries Limited | 3.98 Billion INR | -434.593% |
| Ind-Swift Limited | 5.02 Billion INR | -324.463% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -350.509% |
| Sakar Healthcare Limited | 1.54 Billion INR | -1283.426% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 92.646% |
| Innova Captab Limited | 10.81 Billion INR | -97.242% |
| Divi's Laboratories Limited | 78.45 Billion INR | 72.813% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -64.627% |
| Morepen Laboratories Limited | 17.01 Billion INR | -25.318% |
| Mankind Pharma Limited | 103.34 Billion INR | 79.363% |
| Sequent Scientific Limited | 13.69 Billion INR | -55.709% |
| Wanbury Limited | 5.75 Billion INR | -270.501% |
| Laurus Labs Limited | 50.01 Billion INR | 57.36% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -26.607% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 6.588% |
| Alembic Limited | 1.57 Billion INR | -1254.279% |
| Hikal Limited | 17.84 Billion INR | -19.511% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 65.106% |
| Neuland Laboratories Limited | 15.58 Billion INR | -36.842% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | 38.138% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 81.946% |
| Themis Medicare Limited | 3.81 Billion INR | -458.672% |
| RPG Life Sciences Limited | 5.82 Billion INR | -266.427% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 88.787% |
| Lupin Limited | 196.56 Billion INR | 89.15% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -406.324% |
| Wockhardt Limited | 27.89 Billion INR | 23.529% |
| Vaishali Pharma Limited | 862.79 Million INR | -2371.949% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -17.476% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -921.931% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 68.181% |
| FDC Limited | 19.42 Billion INR | -9.771% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 92.36% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -1281.587% |
| Eris Lifesciences Limited | 20.09 Billion INR | -6.154% |
| Venus Remedies Limited | 5.91 Billion INR | -260.604% |
| ZIM Laboratories Limited | 3.67 Billion INR | -480.324% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -176.898% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -2130.009% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -27.196% |
| Shilpa Medicare Limited | 11.53 Billion INR | -84.96% |
| Albert David Limited | 3.62 Billion INR | -488.418% |
| Ajanta Pharma Limited | 42.08 Billion INR | 49.324% |
| Hester Biosciences Limited | 3.04 Billion INR | -600.318% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -102.861% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -72.223% |
| Gufic Biosciences Limited | 8.06 Billion INR | -164.396% |
| Windlas Biotech Limited | 6.3 Billion INR | -238.025% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -85.257% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -439.104% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -480.582% |
| Granules India Limited | 45.06 Billion INR | 52.672% |
| Aarti Drugs Limited | 25.28 Billion INR | 15.653% |
| Bal Pharma Limited | 3.39 Billion INR | -528.734% |
| Alkem Laboratories Limited | 126.67 Billion INR | 83.163% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 95.602% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -267.374% |
| Medicamen Biotech Limited | 1.79 Billion INR | -1089.468% |
| Unichem Laboratories Limited | 16.57 Billion INR | -28.682% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -1298.865% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -5227.274% |
| Valiant Laboratories Limited | 1.82 Billion INR | -1071.494% |
| Orchid Pharma Limited | 8.19 Billion INR | -160.297% |
| Medico Remedies Limited | 1.44 Billion INR | -1371.695% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -66.507% |
| Ipca Laboratories Limited | 77.05 Billion INR | 72.323% |
| Brooks Laboratories Limited | 794.86 Million INR | -2583.224% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -722.696% |
| Piramal Enterprises Limited | 60.33 Billion INR | 64.652% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 79.89% |
| NATCO Pharma Limited | 40.02 Billion INR | 46.707% |
| Suven Life Sciences Limited | 116.92 Million INR | -18140.043% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -4129.922% |
| Strides Pharma Science Limited | 40.51 Billion INR | 47.353% |
| Indoco Remedies Limited | 18.17 Billion INR | -17.361% |
| Alpa Laboratories Limited | 1.08 Billion INR | -1861.385% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -1944.175% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -2723.194% |